Why Am I Not Losing Weight on Mounjaro 12.5 mg?

If you’re taking Mounjaro (tirzepatide) 12.5 mg and your weight loss has slowed or stopped, you’re not necessarily doing anything wrong. Weight loss with tirzepatide is not always linear, and periods of little or no change on the scales can occur. Mounjaro works alongside a reduced-calorie diet and increased physical activity, and individual responses can vary.

Is a Weight-Loss Plateau on Mounjaro Normal?

A Mounjaro weight-loss plateau can happen even when treatment is working. As body weight decreases, your body’s energy requirements can change, meaning the calorie deficit that previously produced weight loss may become smaller.

It’s also worth looking beyond individual weigh-ins. Water retention, constipation, menstrual-cycle changes, sodium intake and normal day-to-day fluctuations can temporarily mask changes in body fat. Looking at your weight trend over several weeks can provide a more useful picture than focusing on one measurement.

Why Might Mounjaro 12.5 mg Not Be Working?

There are several possible explanations for not losing weight on Mounjaro 12.5 mg.

Your calorie intake may have gradually increased without you noticing, particularly through snacks, drinks, larger portions or calorie-dense foods. Reduced appetite does not necessarily eliminate hunger completely.

Lifestyle factors can matter too. Limited physical activity, poor sleep and changes in eating patterns can influence weight management.

Another possibility is that you are still relatively early in your treatment. Tirzepatide doses are normally increased gradually. NICE guidance states that treatment starts at 2.5 mg once weekly and can be increased in 2.5 mg increments every 4 weeks, up to 15 mg where appropriate.

Does 12.5 mg Mean You Should Be Losing Weight?

Not necessarily. 12.5 mg is not a guarantee of a particular amount of weight loss. The licensed Mounjaro dosing schedule includes 12.5 mg, but NICE identifies 5 mg, 10 mg and 15 mg as recommended maintenance doses for weight management. Any dose change should be determined by your prescriber rather than made independently.

When Should You Speak to Your Prescriber?

If you’ve experienced a prolonged Mounjaro weight-loss plateau, discuss it with your GP, prescribing clinician or specialist weight-management team. They can review your progress, diet, activity levels, other medicines, medical conditions and whether your current treatment remains appropriate.

NICE guidance also recommends reviewing treatment effectiveness. For people taking tirzepatide for weight management, if they have not lost at least 5% of their initial body weight after 6 months on the highest tolerated dose, treatment should be reconsidered.

Don’t Increase Your Dose Yourself

If you’re wondering whether moving from Mounjaro 12.5 mg to 15 mg will restart weight loss, don’t increase the dose without medical advice. Your clinician can determine whether a dose change is suitable and safe for you.

Ultimately, a plateau doesn’t automatically mean that Mounjaro isn’t working. Looking at your longer-term weight trend and discussing persistent lack of progress with a healthcare professional is a safer and more useful approach.